Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)

NCT04707300 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

DRUG: Human T Lymphoid Progenitor (HTLP) injection

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]